October: Breast Cancer Awareness Month

Breast cancer is the most frequent cancer among women, impacting 2.1 million women each year (WHO)

The number one factor that increases the risk of breast cancer is the history of having the disease personally or in the family. Other factors might include poor ecological conditions, exposure to radiation and obesity. The risk of having the disease also increases with age. Early diagnosis is crucial to improving treatment outcomes. Mammography and Clinical Breast Exam (CBE) are the two most popular methods used for screening of breast cancer.

Oncology is one of the main therapeutic areas we focus on at GCT, having performed numerous studies in Breast Cancer over the past few years.

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.


GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login



© 2001—2021 Global Clinical Trials, LLC

All rights reserved.